Colorectal cancer screening recommended for patients aged 50 to 75 years

Share this content:
Adults aged 50 to 75 years should be screened for colorectal cancer.
Adults aged 50 to 75 years should be screened for colorectal cancer.

HealthDay News — The U.S. Preventive Services Task Force (USPSTF) recommends colorectal cancer (CRC) screening starting at age 50 years and continuing through age 75 years. These findings form the basis of a draft recommendation statement, published by the USPSTF.

Researchers from the USPSTF conducted a systematic review of the evidence relating to screening for CRC. They examined the effectiveness or comparative effectiveness of screening tests on CRC incidence and mortality; diagnostic accuracy of screening tests; and harms of screening.

The USPSTF recommends CRC screening for adults aged 50 to 75 years; variation was seen in the risks and benefits of different screening methods (grade A recommendation). For adults aged 76 to 85 years, the decision to screen for CRC should be an individual one based on patient health and prior screening history (grade C recommendation). The draft recommendation statement is available for public comment from Oct. 6 through Nov. 2.

"Colorectal cancer screening is a very effective, but underused, health promotion strategy in the United States," USPSTF member, Douglas K. Owens, MD, said in a statement. "The evidence is clear that adults ages 50 to 75 years will substantially benefit from getting screened, but about one-third of these people have never done so."

References

  1. Draft Evidence Review: Colorectal Cancer: Screening. U.S. Preventive Services Task Force. October 2015. http://www.uspreventiveservicestaskforce.org/Page/Document/draft-evidence-review54/colorectal-cancer-screening2
  2. Draft Recommendation Statement: Colorectal Cancer: Screening. U.S. Preventive Services Task Force. October 2015. http://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement38/colorectal-cancer-screening2
You must be a registered member of Clinical Advisor to post a comment.

Sign Up for Free e-newsletters